ENDO PHARMACEUTICALS HOLDINGS INC (ENDP) is a publicly traded company in the Unknown sector. Across all available filings, 55 corporate insiders have executed 1000 transactions totaling $123.9M, demonstrating a bearish sentiment with -$113.8M in net insider flow. The most recent transaction on Jul 15, 2022 involved a transaction of 280,373 shares valued at $0.
No significant insider buying has been recorded for ENDP in the recent period.
No significant insider selling has been recorded for ENDP in the recent period.
Based on recent SEC filings, insider sentiment for ENDP is bearish with an Insider Alignment Score of 4/100 and a net flow of -$113.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 55 insiders are actively trading ENDP stock, having executed 1000 transactions in the past 90 days. The most active insider is Caroline B. Manogue (Executive), who has made 75 transactions totaling $53.6M.
Get notified when executives and directors at ENDP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | Patrick Tursi James | Executive | Disposition | 280,373 | $N/A | $0 | |
| Mar 30, 2022 | Coleman Blaise | Executive | Option Exercise | 89,663 | $N/A | $0 | |
| Mar 30, 2022 | Coleman Blaise | Executive | Option Exercise | 35,910 | $N/A | $0 | |
| Mar 30, 2022 | Coleman Blaise | Executive | Payment | 10,137 | $2.52 | $25.5K | |
| Mar 30, 2022 | T. Bradley Mark | Executive | Payment | 3,057 | $2.52 | $7.7K | |
| Mar 30, 2022 | T. Bradley Mark | Executive | Option Exercise | 26,805 | $N/A | $0 | |
| Mar 30, 2022 | T. Bradley Mark | Executive | Option Exercise | 10,735 | $N/A | $0 | |
| Mar 30, 2022 | Joseph Maletta Matthew | Executive | Payment | 10,179 | $2.52 | $25.7K | |
| Mar 30, 2022 | Joseph Maletta Matthew | Executive | Option Exercise | 34,414 | $N/A | $0 | |
| Mar 30, 2022 | Joseph Maletta Matthew | Executive | Option Exercise | 85,927 | $N/A | $0 | |
| Mar 30, 2022 | A. Barry Patrick | Executive | Payment | 4,975 | $2.52 | $12.5K | |
| Mar 30, 2022 | A. Barry Patrick | Executive | Option Exercise | 42,341 | $N/A | $0 | |
| Mar 30, 2022 | A. Barry Patrick | Executive | Option Exercise | 16,957 | $N/A | $0 | |
| Mar 29, 2022 | Coleman Blaise | Executive | Payment | 8,437 | $2.52 | $21.3K | |
| Mar 29, 2022 | T. Bradley Mark | Executive | Payment | 2,544 | $2.52 | $6.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 85 | $118.9M | 64.1% |
Payment(F) | 286 | $30.2M | 16.3% |
Exercise(M) | 160 | $29.0M | 15.6% |
Purchase(P) | 39 | $5.0M | 2.7% |
Exercise (Options)(X) | 1 | $2.0M | 1.1% |
Award(A) | 353 | $500.1K | 0.3% |
Disposition(D) | 59 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Gift(G) | 8 | $0 | 0.0% |
Trust Transaction(Z) | 4 | $0 | 0.0% |
Insider selling pressure at ENDO PHARMACEUTICALS HOLDINGS INC has increased, with 55 insiders executing 1000 transactions across all time. Total sales of $118.9M significantly outpace purchases of $5.0M, resulting in a net outflow of $113.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.